Skip to main content
. 2012 Dec 6;6(12):e1930. doi: 10.1371/journal.pntd.0001930

Figure 5. Antibodies to Wb123 fail to normalize following definitive anti-filarial treatment.

Figure 5

IgG (Top panel) and IgG4 (Middle panel) anti-Wb123 antibodies in two individual patients followed longitudinally over an 8 (red line) or 17 (blue line) year period following definitive anti-filarial chemotherapy. Circulating antigen levels in the same two subjects is shown (Bottom panel). Gray shaded boxes show the normal range for each assay.